We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
(-1.1%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-13.41%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$6.54M |
| 2 |
iShares Gold Trust Micro
IAUM
|
+$4.59M |
| 3 |
SPDR Gold MiniShares Trust
GLDM
|
+$3.58M |
| 4 |
Intuit
INTU
|
+$3.2M |
| 5 |
T-Mobile US
TMUS
|
+$2.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.2M |
| 2 |
Microsoft
MSFT
|
+$10M |
| 3 |
NVIDIA
NVDA
|
+$9.7M |
| 4 |
Amazon
AMZN
|
+$7.99M |
| 5 |
Broadcom
AVGO
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.15% |
| 2 | Healthcare | 22.68% |
| 3 | Communication Services | 12.64% |
| 4 | Consumer Discretionary | 11.62% |
| 5 | Consumer Staples | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Humacyte
HUMA
$179M
| $65.1K | 0.01% |
31,155
+5,346
| +21% | +$10.3K |
|
|
EXAS
402
DELISTED
Exact Sciences
EXAS
| $64.6K | 0.01% |
1,216
+1,000
| +463% | +$50.8K |
|
403
Altimmune
ALT
$570M
| $63K | 0.01% |
16,290
+842
| +5% | +$4.56K |
|
404
Invesco Senior Loan ETF
BKLN
$6.75B
| $62.2K | 0.01% |
+2,972
| New | +$61.7K |
|
405
Corvus Pharmaceuticals
CRVS
$1.27B
| $62K | 0.01% |
15,488
+2,599
| +20% | +$9.46K |
|
406
Atea Pharmaceuticals
AVIR
$405M
| $61.9K | 0.01% |
17,188
+246
| +1% | +$734 |
|
|
BCYC
407
Bicycle Therapeutics
BCYC
$284M
| $61.6K | 0.01% |
8,866
+33
| +0.4% | +$263 |
|
|
ATXS
408
DELISTED
Astria Therapeutics
ATXS
| $60.8K | 0.01% |
11,335
+15
| +0.1% | +$73 |
|
409
Olema Pharmaceuticals
OLMA
$913M
| $58.5K | 0.01% |
13,742
-1,150
| -8% | -$5.13K |
|
|
ALMS
410
Alumis Inc
ALMS
$3.26B
| $57.6K | 0.01% |
19,197
+9,725
| +103% | +$45.9K |
|
411
Vanda Pharmaceuticals
VNDA
$314M
| $55.9K | 0.01% |
11,837
+140
| +1% | +$612 |
|
|
SLN
412
Silence Therapeutics
SLN
$641M
| $54.8K | 0.01% |
9,446
+14
| +0.1% | +$60 |
|
413
Cartesian Therapeutics
RNAC
$263M
| $54.2K | 0.01% |
5,213
+115
| +2% | +$1.23K |
|
414
Rocket Pharmaceuticals
RCKT
$374M
| $53K | 0.01% |
21,639
+251
| +1% | +$1.27K |
|
415
Annexon
ANNX
$873M
| $52.9K | 0.01% |
22,036
+655
| +3% | +$1.31K |
|
416
Alpha Teknova
TKNO
$397M
| $52.7K | 0.01% |
10,733
+40
| +0.4% | +$235 |
|
417
Foghorn Therapeutics
FHTX
$394M
| $52.6K | 0.01% |
11,195
+40
| +0.4% | +$167 |
|
418
Entrada Therapeutics
TRDA
$299M
| $51.2K | ﹤0.01% |
7,623
+82
| +1% | +$660 |
|
|
CMPS
419
Compass Pathways
CMPS
$1.97B
| $51.2K | ﹤0.01% |
18,272
+5,817
| +47% | +$21.9K |
|
420
Allogene Therapeutics
ALLO
$714M
| $49.6K | ﹤0.01% |
43,931
+1,874
| +4% | +$2.49K |
|
|
THRD
421
DELISTED
Third Harmonic Bio
THRD
| $49.2K | ﹤0.01% |
9,064
+26
| +0.3% | +$130 |
|
422
MaxCyte
MXCT
$136M
| $46.6K | ﹤0.01% |
21,354
+196
| +0.9% | +$475 |
|
423
Tevogen Inc. Common Stock
TVGN
$27.3M
| $46.2K | ﹤0.01% |
739
+37
| +5% | +$2.11K |
|
424
Neurogene
NGNE
$738M
| $42.8K | ﹤0.01% |
2,864
-116
| -4% | -$1.82K |
|
425
OmniAb
OABI
$497M
| $42.8K | ﹤0.01% |
24,571
+298
| +1% | +$499 |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q2 2025 Portfolio in Review
As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.
- China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
- China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
- China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
- China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
- China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
- China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
- China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.
Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.